A patient with pulmonary hypertension waiting for donor lungs during the pandemic : 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F22%3A00083450" target="_blank" >RIV/00023001:_____/22:00083450 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064165:_____/22:10436227 RIV/00064203:_____/22:10436227 RIV/00216208:11110/22:10436227 RIV/00216208:11130/22:10436227
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/abs/pii/S1600613522000053?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/abs/pii/S1600613522000053?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/ajt.16949" target="_blank" >10.1111/ajt.16949</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
A patient with pulmonary hypertension waiting for donor lungs during the pandemic : 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt
Popis výsledku v původním jazyce
Patients with pulmonary hypertension and end-stage lung disease are fraught with high mortality while on a waiting list for lung transplant. With sometimes rapid deterioration they may require veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as an immediate life-saving technique, which is a time-limited solution. The technique of pulmonary artery to left atrium (PA-LA) shunt fitted with an oxygenator enables bridging the patient to transplant for a longer time period. This low-resistance paracorporeal pumpless lung assist device allows for de-adaptation of the right ventricle back to lower afterload before the lung transplantation is carried out. The PA-LA shunt with an oxygenator also conveys a risk of multiple complications with reported median of 10-26 days until transplant. We report a case of pulmonary capillary hemangiomatosis in a 35-year-old female who had to wait for donor lungs during the pandemic of SARS-CoV-2 for 143 days on PA-LA shunt with oxygenator following 51 days on VA-ECMO. The extremely long course associated with multiple complications including three cerebral embolisms, episodes of sepsis and ingrowth of the return cannula into the left ventricular wall gives insight into the limits of this bridging technique.
Název v anglickém jazyce
A patient with pulmonary hypertension waiting for donor lungs during the pandemic : 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt
Popis výsledku anglicky
Patients with pulmonary hypertension and end-stage lung disease are fraught with high mortality while on a waiting list for lung transplant. With sometimes rapid deterioration they may require veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as an immediate life-saving technique, which is a time-limited solution. The technique of pulmonary artery to left atrium (PA-LA) shunt fitted with an oxygenator enables bridging the patient to transplant for a longer time period. This low-resistance paracorporeal pumpless lung assist device allows for de-adaptation of the right ventricle back to lower afterload before the lung transplantation is carried out. The PA-LA shunt with an oxygenator also conveys a risk of multiple complications with reported median of 10-26 days until transplant. We report a case of pulmonary capillary hemangiomatosis in a 35-year-old female who had to wait for donor lungs during the pandemic of SARS-CoV-2 for 143 days on PA-LA shunt with oxygenator following 51 days on VA-ECMO. The extremely long course associated with multiple complications including three cerebral embolisms, episodes of sepsis and ingrowth of the return cannula into the left ventricular wall gives insight into the limits of this bridging technique.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30201 - Cardiac and Cardiovascular systems
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
American journal of transplantation
ISSN
1600-6135
e-ISSN
1600-6143
Svazek periodika
22
Číslo periodika v rámci svazku
8
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
5
Strana od-do
2094-2098
Kód UT WoS článku
000744081700001
EID výsledku v databázi Scopus
2-s2.0-85122852539